| Literature DB >> 33105396 |
Aaloke Mody1, Kombatende Sikombe2,3, Laura K Beres4, Sandra Simbeza2, Njekwa Mukamba2, Ingrid Eshun-Wilson1, Sheree Schwartz4, Jake Pry1,2, Nancy Padian5, Charles B Holmes6, Carolyn Bolton-Moore2,7, Izukanji Sikazwe2, Elvin H Geng1.
Abstract
BACKGROUND: Patients report varied barriers to HIV care across multiple domains, but specific barrier patterns may be driven by underlying, but unobserved, behavioral profiles.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33105396 PMCID: PMC7722465 DOI: 10.1097/QAI.0000000000002530
Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN: 1525-4135 Impact factor: 3.771
FIGURE 1.Patient flowchart. As of July 1, 2015, 28,117 patients who had ever initiated ART were considered LTFU across 64 sites and 2898 were randomly selected for active tracing from 32 sites. Among patients selected for tracing, 1007 (34.8%) were found alive without a care disruption, 412 (14.2%) had died, and we were unable to trace 932 (32.2%). We ascertained patient-reported reasons for care disruptions among the 547 (18.9%) patients who we found alive with a confirmed care disruption.
Baseline Patient Characteristics
| Baseline Patient Characteristics, n = 547 | |
| Female sex, n (%) | 326 (59.6%) |
| Median age at LTFU, yrs (IQR) | 35 (30–41) |
| Median enrollment CD4 count | 239 (130–366) |
| Enrollment WHO stage, n (%) | |
| I | 234 (42.8%) |
| II | 93 (17.0%) |
| III | 137 (25.0%) |
| IV | 31 (5.7%) |
| Unknown | 52 (9.5%) |
| Median time from enrollment to ART initiation, d (IQR) | 27 (14–85) |
| Median time from ART initiation to LTFU, yrs (IQR) | 1.3 (0.3–3.5) |
| Prior episodes of LTFU, n (%) | |
| 0 | 290 (53.0%) |
| 1 | 165 (30.2) |
| 2 | 63 (11.5) |
| >3 | 29 (5.3%) |
| Marital status, n (%) | |
| Single | 105 (19.2%) |
| Married | 315 (57.6%) |
| Divorced | 74 (13.5%) |
| Widowed | 49 (9.0%) |
| Unknown | 4 (0.7%) |
| Education, n (%) | |
| None | 31 (5.7%) |
| Lower–Mid basic | 199 (36.4%) |
| Upper basic/Secondary | 243 (44.4%) |
| College/University | 67 (12.2%) |
| Unknown | 7 (1.3%) |
| Disclosed HIV status, n (%) | |
| Yes | 472 (86.3%) |
| No | 10 (1.8%) |
| Unknown | 65 (11.9%) |
| Facility type | |
| Urban | 308 (56.3%) |
| Rural | 100 (18.3%) |
| Hospital | 139 (25.4%) |
| Province, n (%) | |
| Lusaka | 235 (43.0%) |
| Eastern | 94 (17.2%) |
| Southern | 123 (22.5%) |
| Western | 95 (17.4%) |
| Care status at time of interview, n (%) | |
| Disengaged | 255 (46.6%) |
| Silently transferred | 292 (53.4%) |
Missing for 103 patients.
IQR, interquartile range; LTFU, loss to follow-up.
FIGURE 2.Profiles of care disruptions (n = 547). Patient profiles of care disruption are based on latent class models based on the patient-reported reasons for care disruptions and the number of reasons a patient reported. The estimated proportion of patients in each latent class are in parentheses at the top, and bars correspond to the probability of reporting a particular reason for care disruption within each class. Models used population-representative sampling weights after tracing a random sample of patients who were considered lost to follow-up as of July 31, 2015.
Metrics of Adequacy and Fit of Latent Class Model
| Metrics of Adequacy and Fit of Latent Class Model | |||||
| Group Average Posterior Probability | Odds Ratio for Correct Classification | Estimated Group Distribution Based on Using Maximal Probability Rule | Estimated Group Distribution Based on Initial Model | Entropy | |
| Livelihood and mobility | 0.983 | 128 | 0.311 | 0.306 | 0.858 |
| Clinic accessibility | 0.940 | 48 | 0.247 | 0.289 | |
| Mobility and family | 0.811 | 12 | 0.270 | 0.219 | |
| Doubting need for HIV care | 0.899 | 80 | 0.100 | 0.102 | |
| Multidimensional barriers to care | 0.951 | 252 | 0.072 | 0.083 | |
Good model fit indicated by 1) average posterior probability greater than 0.7 for each group, 2) odds ratio of correct classification greater than 5 for each group; 3) close correspondence between the estimated group distribution based on using posterior probabilities and the maximal probability rule compared with the estimated group distribution from the initial model; and 4) an entropy greater than 0.8.
Baseline Patient Characteristics by Latent Class
| Baseline Patient Characteristics by Latent Class, n = 547 | |||||
| Livelihood and Mobility | Clinic Accessibility | Mobility and Family | Doubting Need for HIV Care | Multidimensional Barriers to Care | |
| Female sex, percent | 47.4% | 65.6% | 64.4% | 58.2% | 52.0% |
| Median age at LTFU, yrs (IQR) | 37 (31–41) | 36 (30–42) | 35 (28–40) | 36 n(31–42) | 36 (32–39) |
| Median enrollment CD4 count, cells/μL (IQR) | 213 (125–340) | 214 (130–317) | 236 (106–397) | 217 (118–407) | 167 (113–328) |
| Enrollment WHO stage, percent | |||||
| I | 43.0% | 46.7% | 55.7% | 63.7% | 43.1% |
| II | 17.9% | 17.5% | 12.3% | 19.3% | 18.8% |
| III | 30.8% | 32.1% | 27.3% | 15.6% | 34.4% |
| IV | 8.3% | 3.7% | 4.7% | 1.4% | 3.7% |
| Median time from ART initiation to LTFU, yrs (IQR) | 2.0 (0.6–4.2) | 1.4 (0.5–2.9) | 0.9 (0.1–2.7) | 0.2 (0.0–1.6) | 2.7 (0.3–4.0) |
| Prior episodes of LTFU, percent | |||||
| 0 | 34.8% | 52.7% | 58.2% | 68.8% | 51.5% |
| 1 | 37.3% | 38.6% | 28.4% | 19.5% | 27.7% |
| 2 | 21.9% | 5.4% | 9.2% | 3.5% | 9.5% |
| >3 | 6.0% | 3.4% | 4.2% | 8.1% | 11.3% |
| Marital status, percent | |||||
| Single | 19.4% | 13.8% | 21.0% | 19.8% | 29.3% |
| Married | 63.5% | 55.3% | 58.2% | 53.1% | 45.6% |
| Divorced | 11.5% | 17.2% | 15.0% | 9.7% | 19.6% |
| Widowed | 5.6% | 13.8% | 5.8% | 17.3% | 5.5% |
| Education, percent | |||||
| None | 2.2% | 3.4% | 5.2% | 8.5% | 0.5% |
| Lower–Mid basic | 31.6% | 42.7% | 27.8% | 38.5% | 31.0% |
| Upper basic/Secondary | 41.2% | 43.0% | 53.3% | 33.0% | 44.8% |
| College/University | 25.0% | 10.8% | 13.6% | 20.0% | 23.6% |
| Facility type, percent | |||||
| Urban | 75.1% | 75.2% | 67.1% | 79.6% | 67.5% |
| Rural | 3.9% | 4.5% | 6.2% | 6.6% | 13.8% |
| Hospital | 21.1% | 20.3% | 26.7% | 13.8% | 18.7% |
| Province, percent | |||||
| Lusaka | 74.6% | 68.5% | 56.6% | 72.0% | 71.4% |
| Eastern | 5.4% | 9.1% | 14.5% | 9.7% | 4.5% |
| Southern | 6.3% | 12.2% | 15.8% | 14.2% | 15.8% |
| Western | 13.8% | 10.2% | 13.1% | 4.2% | 8.4% |
All values calculated accounting for sampling weights included in the initial latent class model.
IQR, interquartile range; LTFU, loss to follow-up.
Predictive Margins of Latent Class Distribution Across Baseline Patient Characteristics From Multinomial Logistic Regression
| Predictive Margins of Latent Class Distribution Across Baseline Patient Characteristics from Multinomial Logistic Regression, n = 547 | |||||
| Livelihood and Mobility | Clinic Accessibility | Mobility and Family | Doubting Need for HIV Care | Multidimensional Barriers to Care | |
| Overall | 30.6% (25.5% to –36.3%) | 28.9% (20.2% to –39.4%) | 21.9% (16.3% to –28.8%) | 10.2% (5.6% to –18.0%) | 8.3% (3.3% to –19.4%) |
| Sex | |||||
| Female | 27.1% (20.9% to –33.4%) | 29.2% (22.8% to –35.5%) | 28.3% (22.0% to –34.7%) | 8.9% (5.4% to –12.4%) | 6.5% (2.9% to –10.1%) |
| Male | 36.2% (28.1% to –44.3%) | 18.8% (12.5% to –25.2%) | 24.7% (17.0% to –32.4%) | 12.1% (6.5% to –17.8%) | 8.1% (3.4% to –12.9%) |
| Age at LTFU | |||||
| <25 yrs old | 23.3% (9.3% to –37.4%) | 25.8% (11.6% to –40.0%) | 35.5% (18.9% to –52.2%) | 10.7% (0.7% to –20.7%) | 4.7% (0.0% to –10.6%) |
| 25–35 yrs old | 34.2% (26.1% to –42.4%) | 23.6% (16.9% to –30.3%) | 24.7% (17.4% to –32.0%) | 9.8% (4.8% to –14.7%) | 7.7% (3.1% to –12.4%) |
| 35–50 yrs old | 30.3% (23.1% to –37.6%) | 24.3% (17.5% to –31.0%) | 25.4% (18.5% to –32.4%) | 11.2% (6.2% to –16.2%) | 8.8% (4.0% to –13.5%) |
| >50 yrs old | 29.2% (9.1% to –49.3%) | 29.9% (13.3% to –46.5%) | 36.3% (16.6% to –55.9%) | 4.7% (0.0% to –10.2%) | 0.0% (0.0% to –0.0%) |
| Enrollment CD4 count | |||||
| <200 cells/μL | 28.0% (21.3% to –34.6%) | 27.0% (19.7% to –34.2%) | 26.8% (19.8% to –33.9%) | 10.6% (5.1% to –16.0%) | 7.7% (3.3% to –12.0%) |
| 200–350 cells/μL | 33.5% (23.9% to –43.0%) | 29.6% (20.7% to –38.5%) | 23.0% (14.7% to –31.2%) | 7.8% (3.2% to –12.4%) | 6.2% (1.4% to –11.1%) |
| 350–500 cells/μL | 37.5% (24.0% to –51.0%) | 13.3% (5.0% to –21.5%) | 30.9% (17.4% to –44.4%) | 11.0% (2.6% to –19.4%) | 7.3% (0.7% to –14.0%) |
| >500 cells/μL | 31.2% (16.1% to –46.4%) | 16.8% (5.9% to –27.7%) | 32.5% (17.5% to –47.6%) | 12.1% (1.7% to –22.6%) | 7.4% (0.0% to –15.2%) |
| WHO stage | |||||
| I | 29.5% (22.5% to –36.6%) | 21.3% (14.9% to –27.8%) | 29.7% (22.2% to –37.2%) | 12.1% (7.1% to –17.1%) | 7.3% (2.7% to –11.9%) |
| II | 37.5% (23.8% to –51.2%) | 25.3% (14.3% to –36.3%) | 18.2% (9.2% to –27.3%) | 11.9% (3.3% to –20.6%) | 7.1% (1.0% to –13.1%) |
| III | 28.4% (19.5% to –37.3%) | 30.8% (20.5% to –41.0%) | 26.9% (17.0% to –36.9%) | 5.9% (1.8% to –9.9%) | 8.0% (2.9% to –13.2%) |
| IV | 41.7% (17.9% to –65.4%) | 23.4% (1.8% to –45.0%) | 28.9% (7.6% to –50.2%) | 2.8% (0.0% to –8.1%) | 3.3% (0.0% to –7.5%) |
| Time to LTFU | |||||
| <6 mo | 31.3% (19.7% to –42.9%) | 17.7% (9.8% to –25.6%) | 28.3% (19.1% to –37.6%) | 16.9% (7.8% to –26.0%) | 5.7% (1.3% to –10.2%) |
| 6 months-2 yrs | 30.1% (20.6% to –39.7%) | 33.6% (23.9% to –43.3%) | 22.4% (14.7% to –30.1%) | 10.1% (4.5% to –15.8%) | 3.7% (0.0% to –8.5%) |
| 2–5 yrs | 29.5% (19.4% to –39.6%) | 26.6% (17.0% to –36.3%) | 27.6% (17.1% to –38.1%) | 1.9% (0.2% to –3.6%) | 14.4% (4.5% to –24.2%) |
| >5 yrs | 35.4% (21.6% to –49.2%) | 17.6% (7.4% to –27.7%) | 32.8% (17.2% to –48.5%) | 7.6% (0.8% to –14.4%) | 6.7% (0.0% to –14.3%) |
| Prior episodes of LTFU | |||||
| 0 | 22.1% (14.8% to –29.5%) | 29.2% (21.1% to –37.3%) | 30.7% (22.6% to –38.8%) | 9.3% (5.7% to –12.9%) | 8.7% (3.0% to –14.4%) |
| 1 | 35.9% (25.1% to –46.7%) | 24.3% (16.8% to –31.8%) | 24.1% (15.7% to –32.6%) | 10.0% (2.9% to –17.1%) | 5.7% (1.6% to –9.8%) |
| 2 | 54.2% (37.5% to –70.9%) | 12.2% (2.3% to –22.1%) | 21.5% (9.0% to –34.0%) | 8.3% (0.0% to –18.3%) | 3.8% (0.1% to –7.6%) |
| >3 | 25.9% (7.1% to –44.8%) | 12.3% (0.0% to –24.8%) | 15.5% (0.0% to –32.0%) | 33.2% (6.9% to –59.5%) | 13.1% (0.0% to –28.0%) |
| Marital status | |||||
| Single | 35.1% (23.9% to –46.3%) | 17.5% (8.6% to –26.4%) | 25.7% (15.5% to –35.9%) | 10.8% (2.4% to –19.1%) | 10.9% (1.3% to –20.5%) |
| Married | 32.8% (26.2% to –39.5%) | 24.9% (18.7% to –31.1%) | 27.9% (21.9% to –33.9%) | 9.0% (5.2% to –12.8%) | 5.4% (2.6% to –8.1%) |
| Divorced | 23.9% (12.3% to –35.5%) | 25.5% (14.6% to –36.4%) | 32.4% (18.9% to –45.9%) | 7.8% (0.0% to –15.9%) | 10.3% (2.0% to –18.6%) |
| Widowed | 22.6% (7.8% to –37.5%) | 35.7% (18.9% to –52.5%) | 16.9% (5.1% to –28.7%) | 17.8% (5.3% to –30.2%) | 7.0% (0.0% to –17.3%) |
| Education | |||||
| None | 21.2% (−5.0% to 47.3%) | 21.9% (3.3% to –40.4%) | 31.9% (9.6% to –54.3%) | 23.9% (0.0% to –47.9%) | 1.1% (0.0% to –6.7%) |
| Lower–Mid basic | 29.2% (20.6% to –37.8%) | 31.0% (22.3% to –39.7%) | 21.6% (14.6% to –28.5%) | 11.7% (5.5% to –17.9%) | 6.5% (2.7% to –10.4%) |
| Upper basic/Secondary | 30.5% (23.5% to –37.5%) | 23.5% (16.9% to –30.1%) | 31.8% (24.5% to –39.1%) | 7.3% (3.6% to –11.0%) | 6.9% (3.3% to –10.4%) |
| College/University | 37.6% (25.3% to –49.9%) | 16.1% (6.1% to –26.1%) | 24.0% (12.6% to –35.4%) | 11.3% (3.0% to –19.6%) | 11.0% (2.1% to –19.9%) |
| Facility type | |||||
| Rural | 25.7% (11.1% to –40.2%) | 15.7% (7.1% to –24.3%) | 23.4% (14.5% to –32.3%) | 9.6% (2.4% to –16.8%) | 25.7% (10.5% to –40.9%) |
| Urban | 29.0% (23.7% to –34.2%) | 26.7% (21.4% to –32.0%) | 27.8% (22.4% to –33.2%) | 10.7% (7.2% to –14.2%) | 5.9% (2.8% to –8.9%) |
| Hospital | 41.0% (28.4% to –53.5%) | 8.8% (0.2% to –17.5%) | 9.6% (2.4% to –16.8%) | 26.7% (21.4% to –32.0%) | 8.8% (0.2% to –17.5%) |
| Province | |||||
| Eastern | 16.3% (6.9% to –25.7%) | 26.2% (15.9% to –36.4%) | 42.5% (30.4% to –54.7%) | 11.9% (4.0% to –19.9%) | 3.1% (0.0% to –7.8%) |
| Lusaka | 36.1% (29.4% to –42.8%) | 23.4% (17.7% to –29.0%) | 22.3% (16.4% to –28.1%) | 9.6% (5.8% to –13.4%) | 8.6% (4.3% to –13.0%) |
| Southern | 16.2% (7.4% to –25.0%) | 27.5% (16.9% to –38.1%) | 33.9% (23.1% to –44.7%) | 14.7% (7.2% to –22.2%) | 7.7% (1.8% to –13.6%) |
| Western | 29.7% (17.7% to –41.8%) | 27.4% (13.8% to –41.0%) | 33.9% (20.1% to –47.8%) | 5.4% (0.0% to –11.7%) | 3.5% (0.0% to –8.6%) |
LTFU, loss to follow-up.
Association Between Latent Class Membership and Being Out of Care
| Association Between Latent Class Membership and Being Out of Care, n = 547 | ||||||
| Unadjusted | Adjusted | |||||
| Prevalence | Risk Difference | Prevalence | Risk Difference | |||
| Latent class | ||||||
| Livelihood and mobility | 45.6% (35.3% to –55.8%) | REF | <0.001 | 43.6% (34.5% to –52.7%) | REF | <0.001 |
| Clinic accessibility | 62.0% (51.2% to –72.7%) | 16.4% (1.5% to –31.2%) | 62.4% (51.0% to –73.8%) | 18.7% (3.8% to –33.7%) | ||
| Mobility and family | 22.6% (13.6% to –31.6%) | −23.0% (−36.6% to −9.4%) | 23.5% (14.4% to –32.6%) | −20.1% (−33.0% to −7.2%) | ||
| Doubting need for HIV care | 94.0% (85.4% to –100%) | 48.4% (35.0% to –61.7%) | 97.9% (84.2% to –111.6%) | 54.3% (37.0% to –71.6%) | ||
| Multidimensional barriers to care | 64.6% (45.1% to –84.1%) | 19.0% (−3.0% to 41.0%) | 62.8% (44.2% to –81.3%) | 19.2% (−1.9% to 40.2%) | ||
| Sex | ||||||
| Female | 44.5% (37.3% to –51.6%) | REF | 0.030 | 43.0% (36.8% to –49.2%) | REF | 0.005 |
| Male | 56.7% (48.2% to –65.3%) | 12.3% (1.1% to –23.4%) | 59.7% (50.3% to –69.0%) | 16.7% (4.6% to –28.8%) | ||
| Age at LTFU | ||||||
| <25 yrs old | 34.6% (20.1% to –49.1%) | REF | 0.14 | 39.0% (24.0% to –54.0%) | REF | 0.15 |
| 25–35 yrs old | 55.2% (46.5% to –63.9%) | 20.6% (3.7% to –37.5%) | 56.8% (47.9% to –65.7%) | 17.8% (1.1% to –34.5%) | ||
| 35–50 yrs old | 49.9% (41.5% to –58.3%) | 15.3% (−1.5% to 32.1%) | 46.6% (38.9% to –54.2%) | 7.5% (−9.8% to 24.9%) | ||
| >50 yrs | 38.0% (18.1% to –57.9%) | 3.4% (−21.2% to 28.0%) | 44.6% (26.0% to –63.1%) | 5.5% (−18.6% to 29.7%) | ||
| Enrollment CD4 count | ||||||
| <200 cells/μL | 49.9% (41.0% to –58.8%) | REF | 0.90 | 44.8% (37.4% to –52.2%) | REF | 0.24 |
| 200–350 cells/μL | 54.5% (43.7% to –65.3%) | 4.6% (−9.4% to 18.6%) | 51.2% (41.3% to –61.1%) | 6.4% (−6.2% to 19.0%) | ||
| 350–500 cells/μL | 55.0% (39.7% to –70.3%) | 5.1% (−12.6% to 22.9%) | 59.5% (44.4% to –74.7%) | 14.7% (−2.6% to 32.1%) | ||
| >500 cells/μL | 53.4% (36.1% to –70.6%) | 3.5% (−16.0% to 22.9%) | 57.2% (42.5% to –71.9%) | 12.4% (−4.5% to 29.2%) | ||
| WHO stage | ||||||
| I | 49.1% (40.8% to –57.4%) | REF | 0.96 | 48.3% (40.6% to –55.9%) | REF | 0.94 |
| II | 52.1% (38.4% to –65.7%) | 3.0% (−13.0% to 18.9%) | 48.4% (36.8% to –60.0%) | 0.1% (−13.6% to 13.8%) | ||
| III | 52.3% (41.4% to –63.3%) | 3.2% (−10.5% to 17.0%) | 52.2% (41.7% to –62.8%) | 3.9% (−10.3% to 18.2%) | ||
| IV | 52.3% (28.7% to –75.9%) | 3.2% (−21.8% to 28.2%) | 52.9% (29.6% to –76.2%) | 4.6% (−20.9% to 30.1%) | ||
| Time to LTFU | ||||||
| <6 mo | 48.2% (38.5% to –57.9%) | REF | 0.55 | 44.2% (34.2% to –54.2%) | REF | 0.48 |
| 6 months-2 yrs | 53.5% (43.3% to –63.6%) | 5.3% (−8.8% to 19.3%) | 50.7% (41.6% to –59.8%) | 6.5% (−6.8% to 19.8%) | ||
| 2–5 yrs | 52.0% (40.7% to –63.3%) | 3.8% (−11.1% to 18.7%) | 57.3% (44.9% to –69.8%) | 13.1% (−4.8% to 31.0%) | ||
| >5 yrs | 40.8% (26.9% to –54.6%) | −7.4% (−24.3% to 9.4%) | 47.6% (32.0% to –63.2%) | 3.3% (−16.5% to 23.2%) | ||
| Prior episodes of LTFU | ||||||
| 0 | 49.9% (42.3% to –57.4%) | REF | 0.99 | 52.1% (44.4% to –59.8%) | REF | 0.89 |
| 1 | 49.8% (39.8% to –59.7%) | −0.1% (−12.6% to 12.4%) | 47.4% (38.4% to –56.4%) | −4.7% (−17.4% to 7.9%) | ||
| 2 | 48.2% (31.7% to –64.6%) | −1.7% (−19.8% to 16.4%) | 47.7% (31.3% to –64.0%) | −4.5% (−23.6% to 14.7%) | ||
| >3 | 49.9% (25.9% to –73.9%) | 0.0% (−25.1% to 25.1%) | 46.7% (22.3% to –71.0%) | −5.5% (−31.5% to 20.5%) | ||
| Marital status | ||||||
| Single | 51.6% (39.0% to –64.1%) | 2.7% (−11.8% to 17.3%) | 0.53 | 54.8% (43.7% to –65.9%) | 5.6% (−7.8% to 19.0%) | 0.29 |
| Married | 48.8% (41.5% to –56.2%) | REF | 49.2% (42.3% to –56.0%) | REF | ||
| Divorced | 57.1% (43.0% to –71.1%) | 8.2% (−7.6% to 24.1%) | 54.7% (41.7% to –67.6%) | 5.5% (−9.6% to 20.5%) | ||
| Widowed | 40.0% (22.4% to –57.6%) | −8.8% (−27.9% to 10.3%) | 35.6% (20.7% to –50.5%) | −13.6% (−29.9% to 2.7%) | ||
| Education | ||||||
| None | 62.1% (35.7% to –88.4%) | REF | 0.063 | 74.0% (52.9% to –95.1%) | REF | 0.007 |
| Lower–Mid basic | 59.1% (50.0% to –68.2%) | −3.0% (−30.9% to 24.9%) | 56.5% (48.0% to –65.1%) | −17.5% (−40.0% to 5.1%) | ||
| Upper basic/Secondary | 45.2% (37.0% to –53.4%) | −16.9% (−44.5% to 10.7%) | 47.9% (40.1% to –55.6%) | −26.1% (−49.2% to −3.1%) | ||
| College/University | 41.5% (27.4% to –55.6%) | −20.6% (−50.4% to 9.3%) | 37.2% (25.1% to –49.3%) | −36.8% (−60.3% to −13.3%) | ||
| Facility type | ||||||
| Rural | 44.2% (32.5% to –56.0%) | −9.8% (−23.4% to 3.8%) | 0.021 | 43.4% (32.5% to –54.2%) | −7.8% (−20.0% to 4.3%) | 0.41 |
| Urban | 54.1% (47.3% to –60.8%) | REF | 51.2% (45.6% to –56.8%) | REF | ||
| Hospital | 36.1% (26.3% to –45.9%) | −18.0% (−29.9% to −6.0%) | 44.8% (33.6% to –55.9%) | −6.5% (−19.1% to 6.1%) | ||
| Province | ||||||
| Eastern | 43.0% (32.3% to –53.8%) | −12.6% (−25.6% to 0.3%) | 0.007 | 46.0% (35.4% to –56.7%) | −7.5% (−20.6% to 5.6%) | 0.039 |
| Lusaka | 55.7% (48.5% to –62.9%) | REF | 53.5% (47.0% to –60.1%) | REF | ||
| Southern | 35.9% (25.5% to –46.3%) | −19.8% (−32.4% to −7.1%) | 36.2% (27.3% to –45.0%) | −17.4% (−28.6% to −6.2%) | ||
| Western | 33.2% (18.4% to –48.0%) | −22.5% (−39.0% to −6.0%) | 40.4% (24.4% to –56.3%) | −13.2% (−30.7% to 4.3%) | ||
LTFU, loss to follow-up.
FIGURE 3.Estimated prevalence of disengagement by latent class and sex (n = 547). Estimated prevalence of disengagement based on marginal estimates from an adjusted Poisson regression that included an interaction term latent class and sex. Regression model incorporated population-representative sampling weights after tracing a random sample of patients who were considered lost to follow-up as of July 31, 2015. The P-value for the interaction term was 0.246.